RxDoctor Payments Data

Angela Angel

Dallas, TXNPI 1578516654

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,965 of the $3,055 with a category attached, or 64.3%. 28 manufacturers reported payments, led by Mimedx Group, Inc. at 32.7% of the total. 2025 is the largest year on record at $1,269, 4.2 times the $304 reported in 2019.

$3,055in general payments, 2019–2025

Across 110 payments — averaging $27.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mimedx Group, Inc.$1K
  • AbbVie$549
  • Sumitomo Pharma America, Inc.$199
  • Millicent US Inc$143
  • Astellas Pharma US Inc$136
  • Myovant Sciences Inc.$128
  • plus $900 from 22 others

What the payments were for

  • Consulting fees$1,00033%
  • Food & beverage$1,96564%
  • Education$903%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Where these figures come from

Is this you, or does something look wrong? →